Signals detection at the PT level.

<div><p>Sodium zirconium cyclosilicate (SZC) is a novel therapeutic agent for hyperkalemia. However, limited reports have described its real-world safety. In this study, we used the Food and Drug Administration Adverse Event Reporting System (FAERS) database to evaluate the safety profil...

Full description

Saved in:

Bibliographic Details
Main Author:	Yongfei Yu (3083934) (author)
Other Authors:	Kaiyu Zhang (198799) (author), Jinglin Gao (4860148) (author), Guoshun Huang (7161023) (author), Chen Yong (4914118) (author), Yuan Wei (307030) (author), Enchao Zhou (6742928) (author)
Published:	2025
Subjects:	Medicine Cell Biology Pharmacology Biotechnology Science Policy Mental Health Environmental Sciences not elsewhere classified sodium zirconium cyclosilicate novel therapeutic agent median onset time identifies new ones congestive cardiac failure blood potassium abnormal 59 ]), death 26 ]), consistent related adverse events related ae reports sex subgroup analyses limited reports related aes world safety third quarter simultaneously conforming safety profilet safety assessment safe use prior findings fourth quarter four algorithms ebgm ), disproportionality analysis clinical trials clinical settings careful monitoring bcpnn ), based differences 37 ]). 33 days
Tags:	Add Tag No Tags, Be the first to tag this record!

Signals detection at the PT level.

Similar Items